Nucleolar Organiser Regions and Survival in Patients with Non-Hodgkin's Lymphomas Classified by the Working Formulation

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1993 Oct 1

PMID 8227414

Citations 3

Authors

J Jakic-Razumovic

D Tentor

M Petrovecki

I Radman

Affiliations

Soon will be listed here.

Abstract

Aims: To correlate the numbers of silver staining nuclear organiser regions (AgNORs) in non-Hodgkin's lymphoma classified by the working formulation with survival, the first complete remission, and the length of remission.

Methods: Sixty one patients were included in the study. Paraffin wax sections were stained using silver solution to visualise nucleolar organiser regions. The AgNORs were counted in 150 nuclei of each specimen. Data were examined using the Kruskal-Wallis test, multivariate discriminant analysis, and Cox's regression test. Curves were calculated by the method of Kaplan and Meier.

Results: Most patients who were alive had low grade lymphoma (p < 0.01). The first complete remission was obtained more frequently in the low and intermediate grade groups (p < 0.05). The longest survival was found in the low grade group (p < 0.001). The mean number of AgNORs differed significantly in all three groups (p < 0.001). This was also true for area of nuclei (p < 0.001) and length of remission (p < 0.05). In a multivariate analysis the numbers of AgNORs were highly predictive for survival, remission, and the length of remission.

Conclusions: The numbers of AgNORs correlated with survival, remission, and the length of remission in patients with non-Hodgkin's lymphoma.

Citing Articles

Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Acute Leukemia in Adults.

Gajewska M, Rutkowska E, Kwiecien I, Rzepecki P, Sulek K Diagnostics (Basel). 2022; 12(4).

PMID: 35453880 PMC: 9027282. DOI: 10.3390/diagnostics12040832.

Nucleoli and AgNORs in Hodgkin's disease.

Mamaev N, Medvedeva N, Shust V, Markochev A, PASTERNAK N Mol Pathol. 1997; 50(3):149-52.

PMID: 9292150 PMC: 379610. DOI: 10.1136/mp.50.3.149.

Gallbladder cancer. A comparative study among clinicopathologic features, AgNORs, and DNA content analysis.

Ayabe H, Hatano K, Yamaguchi H, Tagawa Y Dig Dis Sci. 1996; 41(5):840-7.

PMID: 8625752 DOI: 10.1007/BF02091520.

References

Brittinger G, Bartels H, Common H, Duhmke E, Fulle H, Gunzer U . Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol. 1984; 2(3):269-306. DOI: 10.1002/hon.2900020306. View

Crocker J, Nar P . Nucleolar organizer regions in lymphomas. J Pathol. 1987; 151(2):111-8. DOI: 10.1002/path.1711510203. View

Crocker J, Macartney J, Smith P . Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol. 1988; 154(2):151-6. DOI: 10.1002/path.1711540207. View

Hall P, Crocker J, Watts A, Stansfeld A . A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology. 1988; 12(4):373-81. DOI: 10.1111/j.1365-2559.1988.tb01952.x. View

Wooldridge T, Grierson H, Weisenburger D, Armitage J, Sanger W, Collins M . Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res. 1988; 48(22):6608-13. View

Howat A, Giri D, Wright A, Underwood J . Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. J Pathol. 1988; 156(3):227-32. DOI: 10.1002/path.1711560307. View

Koziner B, Little C, Passe S, Thaler H, Sklaroff R, Straus D . Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables. Cancer. 1982; 49(8):1571-9. DOI: 10.1002/1097-0142(19820415)49:8<1571::aid-cncr2820490809>3.0.co;2-g. View

Egan M, Ramsden K, Crocker J . Diagnostic significance of mean numbers of nucleolar organizer regions in benign and malignant transitional tumours of nose. Histopathology. 1988; 13(5):579-81. DOI: 10.1111/j.1365-2559.1988.tb02085.x. View

Cowan R, Harris M, Jones M, Crowther D . DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Br J Cancer. 1989; 60(6):904-10. PMC: 2247285. DOI: 10.1038/bjc.1989.388. View

10.

Rehn S, Glimelius B, Strang P, Sundstrom C, Tribukait B . Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol. 1990; 8(1):1-12. DOI: 10.1002/hon.2900080102. View

11.

Macartney J, Camplejohn R, Morris R, Hollowood K, Clarke D, Timothy A . DNA flow cytometry of follicular non-Hodgkin's lymphoma. J Clin Pathol. 1991; 44(3):215-8. PMC: 496940. DOI: 10.1136/jcp.44.3.215. View

12.

Cope C, Rowe D, Delbridge L, Philips J, Friedlander M . Comparison of image analysis and flow cytometric determination of cellular DNA content. J Clin Pathol. 1991; 44(2):147-51. PMC: 496978. DOI: 10.1136/jcp.44.2.147. View

13.

Warnke R, Miller R, Grogan T, Pederson M, Dilley J, Levy R . Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med. 1980; 303(6):293-300. DOI: 10.1056/NEJM198008073030601. View

14.

Crocker J, Egan M . Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas. J Pathol. 1988; 156(3):233-9. DOI: 10.1002/path.1711560308. View